Bangladesh
· Delayed Price · Currency is BDT Advent Pharma Statistics
Total Valuation
Advent Pharma has a market cap or net worth of BDT 2.24 billion. The enterprise value is 2.31 billion.
| Market Cap | 2.24B |
| Enterprise Value | 2.31B |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Advent Pharma has 93.13 million shares outstanding.
| Shares Outstanding | 93.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.31% |
| Owned by Institutions (%) | n/a |
| Float | 65.17M |
Valuation Ratios
The trailing PE ratio is 24.19.
| PE Ratio | 24.19 |
| Forward PE | n/a |
| PS Ratio | 3.93 |
| PB Ratio | 1.52 |
| P/FCF Ratio | 165.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.32, with an EV/FCF ratio of 171.13.
| EV / Earnings | 24.97 |
| EV / Sales | 4.06 |
| EV / EBITDA | 11.32 |
| EV / EBIT | 17.86 |
| EV / FCF | 171.13 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 5.17.
| Current Ratio | 1.07 |
| Quick Ratio | 0.62 |
| Debt / Equity | 5.17 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 5.64 |
| Interest Coverage | 15.69 |
Financial Efficiency
Return on equity (ROE) is 6.46% and return on invested capital (ROIC) is 5.35%.
| Return on Equity (ROE) | 6.46% |
| Return on Assets (ROA) | 4.40% |
| Return on Capital (ROIC) | 5.35% |
| Revenue Per Employee | 1.79M |
| Profits Per Employee | 291,470 |
| Employee Count | 317 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 4.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.45% |
| 50-Day Moving Average | 25.77 |
| 200-Day Moving Average | 26.14 |
| Relative Strength Index (RSI) | 46.23 |
| Average Volume (20 Days) | 974,452 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Advent Pharma had revenue of BDT 568.78 million and earned 92.40 million in profits. Earnings per share was 0.99.
| Revenue | 568.78M |
| Gross Profit | 220.43M |
| Operating Income | 129.13M |
| Pretax Income | 120.77M |
| Net Income | 92.40M |
| EBITDA | 203.19M |
| EBIT | 129.13M |
| Earnings Per Share (EPS) | 0.99 |
Balance Sheet
The company has 4.32 million in cash and 76.04 million in debt, giving a net cash position of -71.72 million or -0.77 per share.
| Cash & Cash Equivalents | 4.32M |
| Total Debt | 76.04M |
| Net Cash | -71.72M |
| Net Cash Per Share | -0.77 |
| Equity (Book Value) | 1.47B |
| Book Value Per Share | 15.79 |
| Working Capital | 15.14M |
Cash Flow
In the last 12 months, operating cash flow was 218.28 million and capital expenditures -204.80 million, giving a free cash flow of 13.48 million.
| Operating Cash Flow | 218.28M |
| Capital Expenditures | -204.80M |
| Free Cash Flow | 13.48M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 38.76%, with operating and profit margins of 22.70% and 16.24%.
| Gross Margin | 38.76% |
| Operating Margin | 22.70% |
| Pretax Margin | 21.23% |
| Profit Margin | 16.24% |
| EBITDA Margin | 35.72% |
| EBIT Margin | 22.70% |
| FCF Margin | 2.37% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.83%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.83% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.29% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.83% |
| Earnings Yield | 4.13% |
| FCF Yield | 0.60% |
Stock Splits
The last stock split was on February 28, 2022. It was a forward split with a ratio of 1.02.
| Last Split Date | Feb 28, 2022 |
| Split Type | Forward |
| Split Ratio | 1.02 |